Insider · CIK 0001026765
Ivor Royston
Files at VIRX (Viracta Therapeutics, Inc.). First filing -, latest -.
In brief
Ivor Royston files SEC Form 4 as director at VIRX (Viracta Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ivor Royston has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | VIRX Viracta Therapeutics, Inc. | MOption exercise Common Stock | +25,219 | $0.00 | $0 | 839,741 | Nov 27, 2024 |
| Nov 25, 2024 | VIRX Viracta Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -25,219 | $0.00 | $0 | 50,438 | Nov 27, 2024 |
Questions about Ivor Royston
Answered from the filings on this page, as of the latest one.
Is Ivor Royston buying or selling?
Ivor Royston has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ivor Royston's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ivor Royston has 0.
Where does Ivor Royston file Form 4?
Ivor Royston has filed Form 4 at VIRX (Viracta Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.